Hematology/Oncology · Greenwood, MS
NPI
1871607598
Since 2006
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
333 Highway 82 W
Greenwood, MS, 38930
Phone (662) 453-3167
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
121,463 services
Medicare patients, 2024
348
Average age 73
Drug cost, 2024
$13.3M
8,192 prescriptions
Company payments, 2025
$3,015
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed S Rafique was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 19,380 times for 21 patients. In total Syed S Rafique billed 121,463 services in 106 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 19,380 | 21 | $0.28 | $5,359 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 7,402 | 36 | $0.09 | $666 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 5,264 | 23 | $0.07 | $393 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,300 | 21 | $15.17 | $35K |
| 85004 Blood Count | Office | 1,838 | 332 | $6.32 | $12K |
| 36415 Venipuncture Blood Collection | Office | 1,675 | 305 | $8.61 | $14K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,630 | 11 | $5.82 | $9,489 |
| 99214 Office E&M - Established | Office | 1,212 | 301 | $83.39 | $101K |
| 80048 Clinical Chemistry | Office | 948 | 297 | $8.26 | $7,831 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 927 | 11 | $3.48 | $3,226 |
| 80076 Clinical Chemistry | Office | 923 | 297 | $7.98 | $7,368 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 860 | 16 | $0.68 | $587 |
| 82728 Clinical Chemistry | Office | 664 | 239 | $13.34 | $8,858 |
| J1750 Injection, iron dextran, 50 mg | Office | 624 | 33 | $13.94 | $8,696 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 580 | 31 | $4.68 | $2,714 |
By year: 2022 $1.9M for 170,728 services; 2023 $1.9M for 211,098 services; 2024 $1.8M for 121,463 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85004 Blood Count | 1,838 | 332 | $6.32 | $12K |
| 36415 Venipuncture Blood Collection | 1,675 | 305 | $8.61 | $14K |
| 80048 Clinical Chemistry | 948 | 297 | $8.26 | $7,831 |
| 80076 Clinical Chemistry | 923 | 297 | $7.98 | $7,368 |
| 82728 Clinical Chemistry | 664 | 239 | $13.34 | $8,858 |
| 80053 Clinical Chemistry | 452 | 213 | $10.33 | $4,668 |
| 82378 Clinical Chemistry | 440 | 127 | $18.50 | $8,138 |
| 86300 Immunoassay | 257 | 81 | $20.39 | $5,240 |
| 85025 Blood Count | 188 | 72 | $7.54 | $1,418 |
| 81007 Clinical Chemistry | 102 | 49 | $29.38 | $2,997 |
Medicare prescription drug claims, 2024
In 2024, the drug Syed S Rafique prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,352 prescriptions and refills. In total Syed S Rafique wrote 8,192 Medicare prescriptions that cost $13.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,352 | 1,355 | 174 | $26K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 595 | 595 | 65 | $13K |
| Anastrozole Generic | 317 | 507 | 64 | $3,590 |
| Zolpidem Tartrate Generic | 251 | 251 | 43 | $1,195 |
| Potassium Chloride Generic | 202 | 241 | 54 | $3,691 |
| Amlodipine Besylate Generic | 191 | 252 | 40 | $516 |
| Keytruda Pembrolizumab | 162 | 163 | 17 | $1.8M |
| Gabapentin Generic | 152 | 157 | 42 | $1,654 |
| Eliquis Apixaban | 141 | 154 | 22 | $89K |
| Letrozole Generic | 140 | 226 | 23 | $1,468 |
| Promethazine Hcl Generic | 118 | 118 | 55 | $816 |
| Alprazolam Generic | 111 | 113 | 16 | $908 |
| Retacrit Epoetin Alfa-Epbx | 110 | 110 | 20 | $181K |
| Pantoprazole Sodium Generic | 108 | 140 | 37 | $945 |
| Fentanyl Generic | 107 | 107 | 15 | $13K |
Brand drugs: - claims; generic drugs: 6,593 claims; opioid claims: 2,194.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed S Rafique $3,015 ($3,015 in general payments such as food, travel and fees) from 38 companies. The largest payer was Gilead Sciences, Inc. with $384.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 14 | $384 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $340 |
| Janssen Biotech, Inc. JNJ | 9 | $235 |
| Exelixis Inc. EXEL | 10 | $147 |
| Pfizer Inc. PFE | 8 | $142 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $141 |
| Adaptive Biotechnologies Corporation ADPT | 5 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $118 |
| Merck Sharp & Dohme LLC MRK | 6 | $112 |
| Celgene Corporation BMY | 5 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.